| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.038 | 0.5 |